We are live on ! Find out more
MCM

Murphy Capital Management Portfolio holdings

AUM $720M
1-Year Est. Return 9.22%
This Fund
S&P 500
This Quarter Est. Return
+8.76%
1 Year Est. Return
-9.22%
3 Year Est. Return
+41.59%
5 Year Est. Return
+78.17%
10 Year Est. Return
AUM
$704M
AUM Growth
+$38.2M
Cap. Flow
-$13.6M
Cap. Flow %
-1.93%
Top 10 Hldgs %
29.08%
Holding
244
New
12
Increased
35
Reduced
139
Closed
12

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$1.75M
2
ROP icon
Roper Technologies
ROP
+$1.28M
3
AAPL icon
Apple
AAPL
+$1.2M
4
KR icon
Kroger
KR
+$603K
5
WTRG icon
Essential Utilities
WTRG
+$579K

Sector Composition

Rank Sector Weight
1 Technology 10.78%
2 Industrials 10.51%
3 Financials 8.34%
4 Communication Services 7.96%
5 Healthcare 7.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ORCL icon
51
Oracle
ORCL
$347B
$3.72M 0.53%
70,259
-1,150
-2% -$63.3K
IHE icon
52
iShares US Pharmaceuticals ETF
IHE
$1.49B
$3.68M 0.52%
68,895
-2,955
-4% -$146K
CSX icon
53
CSX Corp
CSX
$95.4B
$3.59M 0.51%
149,019
-4,275
-3% -$101K
UNH icon
54
UnitedHealth
UNH
$380B
$3.53M 0.5%
12,001
-241
-2% -$63.1K
MA icon
55
Mastercard
MA
$489B
$3.52M 0.5%
11,773
+75
+0.6% +$21.1K
LMT icon
56
Lockheed Martin
LMT
$135B
$3.47M 0.49%
8,924
-70
-0.8% -$26.9K
XLE icon
57
State Street Energy Select Sector SPDR ETF
XLE
$39.1B
$3.31M 0.47%
110,352
-2,920
-3% -$86.6K
IBM icon
58
IBM
IBM
$205B
$3.19M 0.45%
24,862
-2,045
-8% -$266K
BMY icon
59
Bristol-Myers Squibb
BMY
$128B
$3.15M 0.45%
49,164
+16,090
+49% +$921K
CMCSA icon
60
Comcast
CMCSA
$82.3B
$3.09M 0.44%
68,766
-2,625
-4% -$117K
WMT icon
61
Walmart Inc
WMT
$888B
$3.01M 0.43%
76,026
+1,899
+3% +$75.4K
IBB icon
62
iShares Biotechnology ETF
IBB
$9.49B
$2.85M 0.41%
23,689
-1,070
-4% -$119K
LOW icon
63
Lowe's Companies
LOW
$119B
$2.79M 0.4%
23,330
-210
-0.9% -$24K
C icon
64
Citigroup
C
$221B
$2.74M 0.39%
34,314
-575
-2% -$42.5K
IHI icon
65
iShares US Medical Devices ETF
IHI
$3.07B
$2.71M 0.39%
61,500
-1,200
-2% -$50.4K
AXP icon
66
American Express
AXP
$228B
$2.68M 0.38%
21,560
+555
+3% +$66.3K
LLY icon
67
Eli Lilly
LLY
$1.07T
$2.54M 0.36%
19,303
-87
-0.4% -$10.1K
DUK icon
68
Duke Energy
DUK
$100B
$2.48M 0.35%
27,189
-56
-0.2% -$5.13K
GD icon
69
General Dynamics
GD
$106B
$2.48M 0.35%
14,053
-834
-6% -$150K
CSCO icon
70
Cisco
CSCO
$450B
$2.47M 0.35%
51,582
+2,828
+6% +$131K
ED icon
71
Consolidated Edison
ED
$41.2B
$2.44M 0.35%
26,998
-50
-0.2% -$4.48K
PEG icon
72
Public Service Enterprise Group
PEG
$39.4B
$2.4M 0.34%
40,572
+363
+0.9% +$22K
D icon
73
Dominion Energy
D
$61.8B
$2.31M 0.33%
27,906
-1,275
-4% -$104K
AMGN icon
74
Amgen
AMGN
$204B
$2.29M 0.33%
9,523
-172
-2% -$37.9K
PFE icon
75
Pfizer
PFE
$141B
$2.25M 0.32%
60,552
-171
-0.3% -$6.09K

Similar funds

Murphy Capital Management's Q4 2019 Portfolio in Review

As of Q4 2019, Murphy Capital Management held 244 positions worth $704M, up 5.7% from $665M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Murphy Capital Management's Q4 2019 filing shows 12 new, 35 increased, 139 reduced and 12 closed positions. Its largest new stake was ProShares UltraPro QQQ: 24,480 shares worth $264K. The largest sale was Celgene Corp, an estimated $1.75M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 9.9% a quarter earlier, followed by Industrials and Financials.

  • Murphy Capital Management's largest Q4 2019 buy was ProShares UltraPro QQQ: 24,480 shares worth $264K.
  • Murphy Capital Management added most to Bristol-Myers Squibb in Q4 2019, an estimated $921K increase.
  • Murphy Capital Management's biggest Q4 2019 reduction was Apple, cutting an estimated $1.2M.
  • Murphy Capital Management fully exited Celgene Corp in Q4 2019, selling an estimated $1.75M.
  • Murphy Capital Management's ten largest holdings make up 29% of its $704M portfolio in Q4 2019.
  • Murphy Capital Management opened 12 new positions and closed 12 in Q4 2019.
  • Murphy Capital Management's portfolio value rose 5.7% quarter-over-quarter to $704M.

Based on Murphy Capital Management's 13F filing for Q4 2019, filed 10 Feb 2020.